Citius Oncology, Inc. ("Citius Oncology") , an oncology?focused biopharmaceutical company and majority?owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced that ...
Simon May - Senior VP and President of Life Sciences & Diagnostics Markets Group Mike Zhang - Senior VP & President of Applied Markets Group Thank you, Karina, and welcome, everyone, to Agilent's ...
Fragmented subspecialty care and underbuilt survivorship pathways risk overwhelming primary care as the survivor population ...
SAN DIEGO, CA / ACCESS Newswire / May 26, 2026 / Biotech investors spend enormous amounts of time searching for "the next big thing." Most never stop to ask a more important question:What does ...
Brigadier-General Peter Aro (retd.), former Nigerian Army commander and ex-Director of Information and Communication Technology at the Army Signals Headquarters, speaks with SOLOMON ODENIYI on the ...
Scientists have developed a powerful new technique that allows them to observe how individual cells manufacture proteins ...
A core challenge in biology is understanding how processes in the body, such as cellular development and regeneration, unfold ...
The Southern Arizona DUI Task Force patrolled Tucson and surrounding areas over the holiday weekend, looking to detect and deter drunken driving. The task force used sobriety checkpoints and ...
Long-term outcomes of toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: Results from a phase II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results